K-V Pharmaceutical Co - FORM 10-K - EX-21 - LIST OF SUBSIDIARIES - June 10, 2011

Attached files

file filename
10-K - FORM 10-K - K-V Pharmaceutical Cod10k.htm
EX-32.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT18 U.S.C. SECTION 1350 - K-V Pharmaceutical Codex322.htm
EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT18 U.S.C. SECTION 1350 - K-V Pharmaceutical Codex321.htm
EX-23.1 - CONSENT OF BDO USA, LLP - K-V Pharmaceutical Codex231.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) - K-V Pharmaceutical Codex312.htm
EX-23.2 - CONSENT OF KPMG LLP - K-V Pharmaceutical Codex232.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) - K-V Pharmaceutical Codex311.htm

Exhibit 21

KV Pharmaceutical Company

Subsidiaries

(December 13, 2010)

Drugtech Corporation

Drugtech Sarl

ETHEX Corporation

FP 1096, Inc.

KV Pharmaceutical Company Limited (UK)

Nesher (Nesher Israel)

Nesher Discovery Solutions, Inc.

Nesher Pharmaceuticals Inc.

Nesher Solutions USA, Inc. (Nesher USA)

MECW, LLC

Ther-Rx Corporation (Ther-Rx)

Zeratech Technologies USA, Inc.

K-V Pharmaceutical Co Reports